002412 汉森制药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.92010.6309.2198.0826.710
总资产报酬率 ROA (%)2.4658.8617.6156.7435.559
投入资产回报率 ROIC (%)2.78110.0288.5957.3775.986

边际利润分析
销售毛利率 (%)74.23773.22072.06572.43270.303
营业利润率 (%)26.77224.58720.60916.85015.902
息税前利润/营业总收入 (%)26.90523.85520.20117.49916.551
净利润/营业总收入 (%)22.93621.45618.29715.12014.142

收益指标分析
经营活动净收益/利润总额(%)88.78375.78571.63980.25866.476
价值变动净收益/利润总额(%)7.29527.85050.97945.56346.312
营业外收支净额/利润总额(%)-0.108-3.947-3.815-0.247-1.340

偿债能力分析
流动比率 (X)2.7682.5212.2761.5251.929
速动比率 (X)2.1251.8711.6271.2301.620
资产负债率 (%)15.17615.98417.32117.47715.563
带息债务/全部投入资本 (%)3.6304.1045.5446.2479.187
股东权益/带息债务 (%)2,628.8552,315.2561,689.1071,485.497975.935
股东权益/负债合计 (%)558.954525.633477.337472.179542.568
利息保障倍数 (X)166.403118.65557.84825.31119.266

营运能力分析
应收账款周转天数 (天)101.38392.56186.37583.814117.203
存货周转天数 (天)310.551336.050246.182137.496138.891